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ABSTRACT  
Objective: Transdermal patch of timolol maleate was prepared in order to increase the permeability of the drug topically. 
Methods: The timolol maleate (TM) loaded solid lipid nanoparticles (SLN) were prepared by the solvent evaporation method. For the optimization 
process full factorial (three-factor and three-level), hydroxypropyl methylcellulose (HPMC) range from 100 to 300 mg, ethylcellulose 100 to 200 gm 
and almond oil 3 to 4 ml. The response noted in form of tensile strength and percent drug release. These transdermal patches were evaluated for 
physical characterization like weight variation, thickness, percentage moisture absorption, percentage moisture loss, water vapor transmission rate, 
folding endurance, tensile strength, and content uniformity.  
Results: Solid lipid nanoparticles of TM were optimized and prepared, the data presented that drug release percent ranged from 66.12 to 91.75. 2FI 
model was observed to fit for response % drug permeation with a p and F value of 0.0271 and 4.50. The tensile strength varies from 0.358 to 0.508. 
The linear model was observed to fit for the tensile strength response with a p-value and F-value of<0.0001 and 52.41.  
Conclusion: The controlled release formulation of Timolol Maleate was successfully optimized and prepared, a study conducted to investigate the 
effect of different polymers and type of permeation time profiles from Timolol Maleate patches. 
Keywords: Transdermal Patch, Optimization, Drug release, Tensile strength, ANOVA 




Cardiovascular disease (CVD) is viewed as multifactorial in origin. 
Because of the contributions of numerous elements, is influenced by 
different kinds of disorder. Strasser, 1990, has expressed it [1] that 
there are contributions of in excess of 250 risk factors have been 
related to cardiovascular disease. Out of those risk factors, the 
fundamental reasons for the episode of cardiovascular ailments are 
viewed as inherited, age and gender. It is mainly influenced by the 
individual way of life and its method of living. The major risk factors 
associated with cardiovascular disease remain to increase in blood 
pressure and high blood fats along. Aside from these factors, way of 
life with an ordinary intake of smoking and tremendous utilization 
of saturated fats causes distinctive kinds of cardiovascular disease. 
More often than not, it is additionally a result of less physical 
idleness or exercise [2]. 
Day by day, the mortality rate has been increasing all through the 
world. It has been accounted for, that in the western world real 
passing happens as a result of heart diseases, cardiovascular disease 
(CVD) and inappropriate functioning of the circulatory network. This 
report has been representing around 31% of the complete 
worldwide death rate [3]. British Heart Foundation; 2000 
announced that close around 4.35 million passing’s happened each 
year in Europe alone [4]. Out of these close, around 80 % of death is 
among youngsters (<65 y). There are mainly different stages of 
hypertension. 
a). Primary or essential hypertension b). Secondary hypertension  
Development of essential hypertension conditions is on the grounds 
that abnormally high in the blood volume in the body and it grows 
bit by bit and over a long time or years.  
The event of secondary hypertension is observed to be close around 
5-6% of every hypertensive case. In the vast majority of cases, renal 
malfunctioning contributes to the major role for an event of 
secondary hypertension. There are diverse variables like 
race/ethnicity, age, education level, origin of birth, low family pay, 
diabetes, heftiness, handicap status and protection are the thought 
processes in the critical dissimilarities in the predominance of 
hypertension [5].  
As indicated by sources, from 1999 to 2009 the death rate from 
hypertension expanded to be around 17.1 percent [6]. What’s more, 
the real level of death rises to 43.6%. The expansion rate of the 
dreariness and mortality is high that Healthy People 2020 chose to 
diminish the hypertension recurrence among grown-ups by 26.9 
percent and to expand the pervasiveness of hypertension control 
among grown-ups with hypertension to 61.2 percent [7]. The 
transdermal patches were prepared to avoid the first-pass 
metabolism of drug and solid nanoparticles increase the 
permeability of the drug through topical route. 
MATERIALS AND METHODS 
Material 
Timolol maleate (TM) was generously gifted by Gangwal chemicals 
Pvt. Ltd, Mumbai, India. Tween 20 and polyethylene glycol (PEG) 
400 was purchased from SD fine chemicals, compritol 888 ATO from 
Gettefosse (India) Pvt. Ltd; Mumbai, lutrol F68 from BASF, India. 
Hydroxypropyl methylcellulose (HPMC K 100M) was gifted by 
Colorcon Asia Pvt. Ltd; Goa, analytical grades of orthophosphoric 
acid and nylon membrane filters (0.45 µm) were purchased from 
Fisher Scientific (Mumbai, India). All aqueous solutions were 
prepared using Milli Q/Elix water (Millipore, MoscheimCedex, 
France). All other chemicals used were of analytical grade. 
Methods  
Preparation of drug-loaded SLN of TM 
In order to prepare Solid Lipid Nanoparticles (SLN) of TM, the 
weighed quantity of Lutrol F68 and tween 80 are added to purified 
water under stirring to get a clear solution and the temperature 
maintained at 85-90 °C (5% overages of purified water taken to 
compensate loss on heating), Compritol 888 ATO is heated to melt 
to this Timolol maleate is added under stirring to get a clear 
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solution. Above solutions mixed together using ultratrax stirrer at 
13000 rpm for 15 min by maintaining the temp at 85-90 °Cafter 
homogenization the dispersion is kept aside to come to room 
temperature [8, 9]. 
Preparation of SLNs transdermal patches 
Transdermal patches containing Timolol Maleate were prepared up 
by solvent casting technique-utilizing mercury a role as substrate. 
Different formulations were formulated utilizing different grades of 
hydroxyl propyl methylcellulose (HPMC) for example HPMC K100M, 
HPMC 50 cps, and ethyl acetate, distinctive level of polyethylene 
glycol and 100 mg of optimized nanoparticles added gradually to the 
solution and mixing for 30 min. The mold was kept on a mercury 
surface. Around 4 ml of the prepared solution was poured on the 
mercury [10, 11]. The rate of evaporation was constrained by 
inverting the funnel over the mold. After 12 h, the dried patches 
were cut into 2.2 cm width, enclosed by aluminium foil and put away 
over fused calcium chloride in a desiccator at room temperature for 
further use. 
Statistical optimization of the formulation variables using a 
factorial experimental design 
For the better physic-synthetic property of prepared patch was an 
attempt to utilize HPMC 50cps and ethyl cellulose as independent 
factor X1 and X2 for the optimization of the final formulation by 
using full factorial 33
 
 (three-factor and three-level) by using Design 
Expert 11 Trial Version Software. Permeation of pure drug improves 
with almond seed oil and it was adequate to accomplish focused on 
targeted flux to maintained therapeutic concentration and 
controlled release of drug for a predetermined period. In this way, 
concentration of almond oil as a permeation enhancer select as 
another independent factor X3. The design involved two dependent 
variables (Y1 and Y2) and above mentioned three independent 
variables (X1, X2, and X3). The dependent variable Y1 was tensile 
strength (TS) of prepared patches, Y2 was percent drug release 
(table 1). After completion of statistical optimization experiments, 
polynomial equations and contour plots generated to study the 
effect of selected independent variables on dependent variables in 
order to identify the optimized drug-loaded transdermal patch. 
Table 1: Variables and their levels in 33
Variables  
 level factorial experiments design for patches 
Units Type Low Medium  High 
A- HPMC Mg Factor -1 0 +1 
B- Ethyle cellulose Mg Factor -1 0 +1 
C- Almond Oil Ml Factor -1 - +1 
Tensile strength Kg/mm2 Response - - - 
% drug release % Response - - - 
Variables  Low Medium  High 
A- HPMC 100 200 300 
B- Ethylcellulose 100 150 200 
C- Almond Oil 3 - 4 
 
Physico-chemical parameter of the transdermal patch formulation 
was carried out in terms of weight variation, thickness, percent 
moisture absorption, percent moisture loss, water vapor 
transmission rate and folding endurance [12]. 
To analyze the adequacy of models, trial information, and 
experimental data were fitted to various polynomial models 
including linear, interactive, cubic and quadratic and statistical 
tests such as a sequential model sum of squares. Selected the 
highest order polynomial where the terms are significant and the 
model is not aliased. Highest order polynomial was selected in that 
the additional terms are significant and the model is not aliased. 
RESULTS 
Timolol maleate transdermal patches were prepared by using the 
solvent casting technique. For optimization process full factorial 
design (33
 
three-factor and three-level), different 18 formulations 
prepared as per design at different level responses as tensile 
strength and % drug release noted as per formulations (table 2). 
Formulation having the highest percent drug release (91.75%) and 
highest tensile strength (0.508) prepared by using (table 3). HPMC 
50 cps 300 mg, ethylcellulose 100 mg and 4 ml almond oil. 
Table 2: Variables and their levels in 33 level full factorial experiments design for patches 
  Factor 1 Factor 2 Factor 3 Response 1 Response 2 
Std Run A: HPMC 50 B: Ethyl C: Almond Tensile % Drug 
  Cps Cellulose Oil Strength Release 
  Mg Mg Ml Kg/mm % 2 
1 1100 100 3 0.369 66.12 
11 2200 100 4 0.453 76.91 
3 3300 100 3 0.494 81.41 
2 4200 100 3 0.451 72.45 
16 5100 200 4 0.358 72.49 
18 6300 200 4 0.485 78.45 
5 7200 150 3 0.429 70.45 
7 8100 200 3 0.386 68.35 
14 9200 150 4 0.437 72.61 
8 10200 200 3 0.456 71.32 
4 11100 150 3 0.403 69.43 
10 12100 100 4 0.401 69.34 
15 13300 150 4 0.503 83.45 
6 14300 150 3 0.478 77.59 
12 15300 100 4 0.508 91.75 
17 16200 200 4 0.459 73.48 
13 17100 150 4 0.382 70.26 
9 18300 200 3 0.479 78.32 
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Table 3: Variables and their levels in 33 level factorial experiments design for patches 
Name Units Type Low High 
HPMC 50 cps Mg Factor 100 300 
Ethylcellulose Mg Factor 100 200 
Almond oil Ml Factor 3 4 
Tensile strength Kg/mm Response 2 Maximizing  
% Drug release %age Response Maximizing 
 
Table 4: Fit summary model for the measured responses R1 and R2 for the patch, response 1: tensile strength 
Source Sequential p-value Adjusted R² Predicted R²  
Linear <0.0001 0.9007 0.8614 Suggested 
2FI 0.3999 0.9023 0.7999  
Quadratic 0.3883 0.9032 0.7768 Aliased 
 
Table 5: Sequential model sum of squares 
Source Sum of squares df Mean square F-value p-value  
Mean vs Total 3.49 1 3.49    
Linear vs Mean 0.0353 3 0.0118 52.41 <0.0001 Suggested 
2FI vs Linear 0.0007 3 0.0002 1.07 0.3999  
Quadratic vs 2FI 0.0005 2 0.0002 1.05 0.3883 Aliased 
Residual 0.0020 9 0.0002    
Total 3.53 18 0.1963    
 
Table 6: Fit summary model for the measured responses R1 and R2 for the patch, response 2: % drug release 
Source Sequential p-value Adjusted R² Predicted R²  
Linear <0.0001 0.7568 0.6455  
2FI 0.0271 0.8611 0.7008 Suggested 
Quadratic 0.0279 0.9233 0.7644 Aliased 
 
Table 7: Sequential model sum of squares 
Source Sum of squares df Mean square F-value p-value  
Mean vs Total 1.004E+05 1 1.004E+05    
Linear vs Mean 550.31 3 183.44 18.63 <0.0001  
2FI vs Linear 75.96 3 25.32 4.50 0.0271 Suggested 
Quadratic vs 2FI 33.93 2 16.97 5.47 0.0279 Aliased 
Residual 27.93 9 3.10    
Total 1.011E+05 18 5614.83    
 
Table 8: Analysis of variance table for measured responses for patch response 1: Tensile strength 
Source Sum of squares df Mean square F-value p-value  
Model 0.0353 3 0.0118 52.41 <0.0001 significant 
A-HPMC 50 cps 0.0350 1 0.0350 155.78 <0.0001  
B-Ethyl cellulose 0.0002 1 0.0002 1.04 0.3247  
C-Almond oil 0.0001 1 0.0001 0.4157 0.5295  
Residual 0.0031 14 0.0002    
Cor Total 0.0385 17     
The F-value of the model is 52.41 shows model is significant. P-values are less than 0.0500 indicate that the model is significant. 
 
Table 9: Fit statistics (Tensile strength) 
Std. Dev. 0.0150 R² 0.9182 
Mean 0.4406 Adjusted R² 0.9007 
C. V. % 3.40 Predicted R² 0.8614 
  Adeq Precision 17.1812 
The Predicted R2 of 0.8614(table 4) is in reasonable agreement with the Adjusted R2 of 0.9007; i.e. the difference is less than 0.2. A ratio greater 
than 4 is desirable. Here the ratio of 17.181 indicates an adequate signal (table 5). This model can be used to navigate the design space (fig. 1). 
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Table 10: Analysis of variance table for measured responses for patch response 2: % drug release 
Source Sum of squares df Mean square F-value p-value  
Model 626.26 6 104.38 18.56 <0.0001 significant 
A-HPMC 50 cps 468.50 1 468.50 83.31 <0.0001  
B-Ethyl cellulose 20.20 1 20.20 3.59 0.0846  
C-Almond oil 61.61 1 61.61 10.95 0.0070  
AB 59.24 1 59.24 10.53 0.0078  
AC 5.52 1 5.52 0.9818 0.3430  
BC 11.19 1 11.19 1.99 0.1859  
Residual 61.86 11 5.62    
Cor Total 688.13 17     
The Model F-value of 18.56 (table 6) implies the model is significant and 0.01% chance that an F-value this large could occur due to noise. P-values 
less than 0.0500 indicate model terms are significant (table 7). 
 
Table 11: Fit statistics (% Drug release) 
Std. Dev. 2.37 R² 0.9101 
Mean 74.68 Adjusted R² 0.8611 
C. V. % 3.18 Predicted R² 0.7008 
  Adeq Precision 15.9383 
The Predicted R2 of 0.7008 is an insensible agreement with the Adjusted R2 of 0.8611; for example, the thing that matters is under 0.2. A proportion 
more noteworthy than 4 is desirable. Here the proportion of 15.938 demonstrates a sufficient signal (table 8). This model can be utilized to explore 






Fig. 1: Linear correlation plot (a) between actual and predicted values of the tensile strength (R1), (b) between actual and predicted 
values of % drug release (R2) 
Parveen et al. 









Fig. 2: Contour plot 3D response surface plot and a cubic plot showing the effect of HPMC and Ethylcellulose on response R1 (tensile 
strength) 
Parveen et al. 









Fig. 3: Contour plot 3D response surface plot and a cubic plot showing the effect of HPMC and ethyl cellulose on response R2 (% Drug 
release) 
Parveen et al. 
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Table 12: Optimized formulation factors 
Factors Optimum  
HPMC 200 
EC 100 
Almond oil 3 
Response Predicted Observed Residual Prediction error (%) 
%drug release 73.16 73.80±0.3 0.87 
Tensile strength0.4427 0.4603±0.0176 3.97 
(Resudual= predicted-observed value, Prediction error= Predicted value-Observed value/Predicted value*100) 
 
Effect of formulation variables on tensile strength of the film 
ANOVA used to assess experimental information and p-value 
estimation of regression coefficients utilized to measure significance, 
as shown in table 8. Tensile strength is a decent way to break down 
the mechanical properties of the film. 
A delicate film has low percent lengthening and tensile strength 
while the hard and weak film is described by low stretching and 
moderate tensile strength. In this way, so to diminish the fragility of 
film and expand the flexibility of film required level of plasticizer is 
incorporated.  
After adding plasticizer the tensile strength increases from 0.358 to 
0.508. A linear model was seen to fit for the tensile strength response 
with a p-value and F value of<0.0001 and 52.41. It was revealed that 
linear coefficients (A, B, C) were noteworthy for the picked model. P-
value was utilized to interaction strength quality among factors and 
centrality of individual coefficients (fig. 2). It is obvious from the 
response surface plot that the concentration of almond oil and HPMC 
50 cps rate are the huge factors influencing the tensile strength in a 
positive way with a p-value of<0.0001. Permeation enhancers 
debilitate the attachment powers between polymer chains and hence 
improving the flexibility of polymer matrix [13, 14].  
The precision of the model to decide the tensile strength of the film 
was confirmed by the ANOVA of observed value, which yielded a 
linear relationship with R2 value of 0.8614 Kg/mm2 
Tensile strength = 0.329917+0.000540* HPMC 50 cps-0.000088* 
Ethylcellulose+0.004556* Almond oil. 
[15]. The linear 
equation generated by the software is given below:  
Effect of formulation variables on % drug permeation of the 
film 
ANOVA was utilized to assess experimental information and p-
estimation of regression coefficients were utilized to measure 
significance as appeared table. For the most part, the drug 
permeation is a decent tool to outline the dissolution attributes of 
the film [16, 17]. A film that has low drug permeation has poor 
disintegration properties (table 9). The utilization of the best 
possible level of permeation enhancer and the type and amount of 
hydrophilic/hydrophobic polymer improves (fig. 3) the medication 
release from the film [18].  
The information exhibited that distinguished release percent ran 
from 66.12 to 91.75. 2FI model was seen to fit for response % drug 
release with a p and F value of 0.0271 and 4.50. For this model linear 
coefficients, A and B were observed to be significant. P-value was 
utilized to decide the significance of individual coefficients and 
collaboration strength between factors. From response surface plot 
it is observed that the concentration of HPMC 50cps and oils are the 
major factors affecting the drug release percent in positive pattern 
with a p-value of 0.0271. (table 10) The precision of the model was 
affirmed by the R2
% Drug release=+26.00917+0.096637* HPMC 50 cps+0.218117* 
Ethyl cellulose+6.78167* Almond oil-0.000544* HPMC 50 cps * 
Ethyl cellulose+0.013567* HPMC 50 cps * Almond oil-0.038633* 
Ethylcellulose * Almond oil. 
 value (0.7008%) for patches as dictated by the 
ANOVA of the watched qualities, which yielded linear relationships 




Fig. 4: SEM photograph of transdermal patch of HPMC 50 cps showing homogenous dispersion of drug in the patch 
 
DISCUSSION 
Transdermal patch prepared by the solvent casting technique was 
transparent, non-adhesive, homogeneous and smooth appearance. 
Phosphate buffer with tween 80 used for drug permeation study was 
optimal for drug release study. All the parameter like folding 
endurance, thickness, weight variation, Tensile strength, and % drug 
release was also found near uniform and optimal.  
Effect of formulation variables on the tensile strength of the film is a 
decent way to break down the mechanical properties of the film (fig. 
4). A delicate film has low percent lengthening and tensile strength, 
while the hard and weak film is described by low stretching and 
moderate tensile strength. It was observed in plotting another 
surface graph that, an increase in HPMC extent in the polymer blend 
gives higher tensile strength to the film. It revealed that with 
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increment in the amount of EC (hydrophobic polymer), a decline in 
tensile strength was observed. It very well may be inferred that the 
preparation containing high convergence of HPMC 50 cps and 
almond oils has higher tensile strength [16, 18] 
Effect of formulation variable on the percent drug release reveals 
that A film that has low drug permeation has poor disintegration 
properties. The utilization of the best possible level of permeation 
enhancer and the type and amount of hydrophilic/hydrophobic 
polymer improves the medication release from the film. From the 
equation, it is concluded that the two factors A and C have a positive 
effect on the % drug permeation of the film. It was seen that the 
increase in HPMC 50 cps and almond oils rate has a coordinate effect 
on the film’s drug penetration. With the increase in oil amount (3-4 
ml) and HPMC 50 cps (300-100 mg) concentration, drug release was 
found to increment. linear correlation plots are shown among 
observed and anticipated values for the response. The predicted R2 
value if there should be an occurrence of patches (0.7008) was in 
complete agreement with adjusted R2
CONCLUSION 
 value (0.8616) as the 
distinction between the two was observed to be under 0.2. 
Permeation enhancers decline the lag time which happens because 
of a decline in diffusional path length of drug which is ascribed to 
changes in stratum corneum [19].  
The transdermal patches of timolol maleate were prepared 
successfully. In the formulations increase in HPMC 50 cps 
concentration results in the quicker dissolution of polymer matrix 
bringing about the development of channels for the dissemination of 
drugs from the film. Almond oils additionally add to great 
permeation of Timolol maleate. As a final point after investigation of 
experimental factors, an ideal formulation of Timolol maleate film 
containing almond oil with adequate medicament release and 
elongation was determined to contain 200 mg HPMC 50 cps, 100 mg 
Ethyl Cellulose and 3 ml of almond oil. The anticipated values of 
responses for the optimized transdermal film were very close to the 
observed qualities with no extensive expectation error % and 
residuals. This result affirms that the optimization technique utilized 
is exceedingly solid and reproducible for the advancement of 
Timolol maleate patch with high-quality attributes.  
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